Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

MEI Pharma Q3 GAAP EPS $(0.39) Up From $(1.37) YoY

Author: Benzinga Newsdesk | May 13, 2025 05:02pm
MEI Pharma (NASDAQ:MEIP) reported quarterly losses of $(0.39) per share. This is a 71.53 percent increase over losses of $(1.37) per share from the same period last year.

Posted In: MEIP


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist